A PHASE I STUDY TO EVALUATE THE EFFECT OF FOOD AND GASTRIC ACID SUPPRESSION ON THE PHARMACODYNAMIC EFFECT OF A NOVEL ORAL RECOMBINANT SALMON CALCITONIN
Nighttime Dosing With An Oral Calcitonin Tablet Significantly Reduces Plasma CTx-1
IN VITRO MODEL FOR CALCITONIN AS A COMBINATION THERAPY FOR OSTEOARTHRITIS
GRIBOI 2011-Rapid Site-Specific Bone Growth by a Combination of Bone Marrow Irrigation, Bone Compatible Cement and PTH Therapy
American Society for Bone and Mineral Research (ASBMR) 2011: “Clinical Development of An Orally Delivered Recombinant PTH Analog”
Results of the ORACAL Trial: A Phase 3 Randomized Trial of the Safety and Efficacy of Orally Administered Recombinant Salmon Calcitonin Tablets
